THERAPEUTIC COMBINATION OF CELL-MEDIATED CYTOTOXIC THERAPY AND A BCL2 FAMILY PROTEIN INHIBITOR PRO-SURVIVAL

MA56206AUndetermined Publication Date: 2022-04-20JUNO THERAPEUTICS INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA56206
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2019-08-22
Filing Date: 2020-06-11
Publication Date: 2022-04-20

Application Information

Patent Timeline

22 Aug 2019

Priority

11 Jun 2020

Application

MA56206

20 Apr 2022

Publication

MA56206A

IPC: A61K39/00; A61P35/00; A61P35/02

CPC: A61P35/02; A61K2039/804; A61K2300/00; C07K14/7051; C12N5/0636; C12N2501/48; A61K31/635; A61K31/404

Inventors: AMIN Rupesh; BRAHMANDAM Archana

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Need to check novelty before this filing date? Find Prior Art

No text content released.